Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108, Freiburg, Germany
Budenofalk 2mg/dose rectal foam.
Pharmaceutical Form |
---|
Rectal foam, pressurised container. White to pale white, creamy firm foam. |
Each dose of 1.2 g foam contains 2 mg of budesonide.
Excipients with known effect: cetyl alcohol, propylene glycol.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Budesonide |
Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. |
List of Excipients |
---|
Cetyl alcohol Propellant: n-Butane |
Aluminium pressurised container with metering valve together with 14 PVC applicators coated with white soft paraffin and liquid paraffin for administration of the foam and 14 plastic bags for hygienic disposal of the applicators.
Pack sizes:
Original pack with 1 pressurised container, contains at least 14 doses of 1.2 g rectal foam each.
Original pack with 2 pressurised containers, contains at least 2 × 14 doses of 1.2 g rectal foam each.
Hospital pack with 1 pressurised container, contains at least 14 doses of 1.2 g rectal foam each.
Not all pack sizes may be marketed.
Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108, Freiburg, Germany
PL08637/0011
Date of first authorisation: 15 Jun 2006
Date of last renewal: 15 Jun 2011
Drug | Countries | |
---|---|---|
BUDENOFALK | Australia, Cyprus, Estonia, Finland, Hong Kong, Ireland, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.